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Abstract 
 
 
 Bidirectional communication between mammalian oocytes and their 
surrounding somatic cells is essential for oocyte maturation. Gap junctions promote 
the transfer of essential metabolites, nucleotides, amino acids and ions from cumulus 
cells to the oocyte that are crucial for oocyte growth and development. However, the 
range of factors present in the microenvironment of the developing antral follicle, 
which modulate gap junction activity of the cumulus-oocyte complexes (COCs), is 
largely unknown.  
 The primary objective of this study was to determine the effects of various 
steroids, growth factors and cAMP stimulators on the gap junction activity in rat 
COCs. The gap junction activity was measured in presence or absence of different 
treatments using a fluorescence dye and in the presence of milrinone, a 
phosphodiesterase type 3 inhibitor.  
 The major findings of this study were that cAMP stimulators increased the rate 
of dye transfer from cumulus cells to the oocyte. Under in vitro conditions it was 
established that neither steroids nor IGF1 by themselves were able to modulate gap 
junction activity in rat COCs. Furthermore, forskolin, a potent cAMP stimulator; 
caused a relative increase in Cx37 gene expression levels following a four hours 
incubation period.  
 The outcomes from the present study may help to provide new insights into 
developing suitable in vitro conditions, for the in vitro maturation of mammalian 
oocytes.   
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INTRODUCTION 
 
 
 
1.1 In Vitro Maturation  
 
In-vitro maturation (IVM) is a process which involves retrieving immature 
cumulus-oocyte cell complexes (COC) from ovarian antral follicles and subjecting 
these to a maturation process before undergoing an in vitro fertilisation procedure 
(IVF). For IVM, the COC are usually recovered under the guidance of an ultrasound 
procedure from donors who are not subjected to a course of exogenous hormone 
treatments that normally occurs with the IVF procedure. Thereafter, the COC are 
matured in a defined culture medium for 24-48 hours (1). During this interval the 
oocytes mature, resume meiosis and the cumulus cells lose their attachments with one 
another and the oocyte. The resulting oocytes that have reached metaphase II after this 
time are then fertilised by adding sperm to the culture wells or by a process known as 
intracytoplasmic sperm injection (ICSI). Two to three days after fertilisation, selected 
embryos are transferred to the donors. While IVM has a greater laboratory-based 
commitment it is considered to have the potential to be more cost-effective, safer and 
less time consuming than current IVF procedures.  
In a standard IVF treatment, the women donors are subjected to two weeks of 
hormone injections to stimulate maturation of multiple ovarian follicles. IVM avoids 
the use of multiple hormone treatments, involves a reduced level of monitoring of 
patients and is therefore less costly and demanding for the donor (1). It also has the 
potential to utilise large numbers of immature oocytes from developing antral 
follicles. As well as being time-consuming and expensive, a potentially serious side-
effect of hormone injections in IVF is a condition known as ovarian hyperstimulation 
syndrome (OHSS) caused by to excessive ovarian response to exogenous hormones 
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(1). Furthermore, IVM potentially offers a safer treatment for women with Polycystic 
Ovary Syndrome (PCOS). Women with PCOS have a tendency to have a vigorous 
response to ovarian stimulation and are at significant risk of OHSS. A milder 
stimulation treatment as envisaged by IVM would be expected to reduce this risk (1).  
Thus, IVM is considered to be the next important addition to the portfolio of artificial 
reproductive technologies as it has the potential to utilise large numbers of immature 
oocytes from developing antral follicles.  
Pregnancy rates following IVM are reported to be variable (4-54%) and 
generally lower than IVF (1, 2). Nevertheless, more than 300 children have been born 
worldwide through IVM treatment (2, 3). With IVF, delivery rates (i.e. of live-born), 
up to 59% have been achieved for fresh and frozen transfers following IVF (4) 
whereas in IVM, significantly lower delivery rates of around 13% have been achieved 
thus far (2).  
To increase the efficacy of IVM technology, one great challenge is to 
understand the role that the ovarian follicular microenvironment surrounding the 
oocyte plays in its progress to become fully competent (5). IVM differs to natural in 
vivo oocyte maturation in two ways: Firstly, COC are collected from antral follicles 
that include oocytes that have not completed capacitation as oocytes only acquire 
meiotic and developmental competence during the final stages of folliculogenesis (5). 
Thus, premature recovery of COC from immature antral follicles hinders the 
progression of oocytes to acquiring meiotic and developmental competence (5). 
Secondly, removing COC from their follicular microenvironment results in loss of the 
natural meiotic inhibiting factors which can result in spontaneous meiotic maturation 
of the oocyte in vitro before competence has been acquired (5). The loss of these 
meiotic inhibitory factors leads to premature breakdown of gap junctions in COC, in 
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turn causing loss of beneficial cumulus cell metabolites, such as ions, amino acids and 
nucleotides needed for oocytes in their progress to acquiring meiotic competence (6).  
Thus a key challenge to enhance IVM efficacy involves improving oocyte 
developmental competence by maintaining the integrity of the COC, delaying 
spontaneous nuclear maturation and providing the appropriate in vitro culture 
microenvironment to ensure that the oocyte is able to acquire meiotic competence 
before attempting IVF (5). Theoretically, the objective of this approach is to increase 
oocyte-cumulus gap-junctional communication in vitro to allow ooplasm development 
since gap junction mediated transport of molecules initially taken up by the granulosa 
cells is essential for metabolic processes crucial for oocyte growth and cytoplasmic 
development. The question arises as to what are the key factors present in the 
follicular microenvironment that are important for influencing gap- junction activity 
in COC. 
 
1.2 Follicular development  
 
1.2(i) The Mammalian Ovary 
 
The female reproductive system includes two ovaries and a reproductive tract 
with uterine tubes, uterus and vagina. The ovaries are almond- sized organs in the 
upper pelvic cavity, one on each side of the uterus. The ovary is covered normally by 
a single layer of cells which constitutes the surface epithelium. The two main 
morphological regions of the ovary are referred to as the cortex and medulla. The 
cortical region encompasses most, if not all, of the growing and non-growing follicles 
(Figure 1) and corpora lutea separated by stromal or interstitial cells and blood 
capilliary vessels. The medulla incorporates all the innermost parts of the ovary and 
the hilum by which the ovary is attached, and through which the blood, nerves and 
lymphatic vessels enter (7). 
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Figure 1.1:- The sheep ovary (upper left) with solid arrows indicating surface visible 
follicles and open arrows indicating corpus luteum, primordial follicle (lower left) 
showing a large oocyte and centrally-located nucleus with three darkly-stained 
granulosa cells around the periphery of the oocyte, and section though the ovarian 
cortex (right hand image) showing preantral follicles immediately below the ovarian 
surface epithelium and a series of growing preantral and antral follicles with the 
uppermost antral follicle displaying both mural granulosa cells and cumulus cells 
immediately adjacent to the oocyte surrounded by follicular fluid. On the extreme 
right hand side a large antral follicle is partly visible with the mural layer of granulosa 
cells and a large fluid-filled cavity (Figure supplied by Professor Ken McNatty). 
 
 
The ovary, follicles and oocytes
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1.2(ii) Development of the Oocyte: Oogenesis   
In most mammals (e.g. primates, ruminants, rodents) oogenesis begins during 
fetal development. At birth or shortly afterwards, females will contain all the germ 
cells (oocytes) she will ever have during her lifetime. In human females, the number 
oocytes (i.e. often referred to as eggs) have been estimated to be between 2-4 million 
(8). Out of this vast population of eggs, only a few are destined to be ovulated with all 
others undergoing degeneration at some point in their development. During early fetal 
development (Figure 1.2), oogenesis begins with primordial germ cell formation and 
involves a series of transformations, from primordial germ cells to oogonia and then 
to oocytes (9).  
 
  
 Figure 1.2:- Representation of oogenesis in mammals 
Primordial germ cells 
Oogonia 
     Primary oocyte 
(Follicular formation) 
 
 
 
Initiation of 
meiosis 
Leptotene 
Zygotene 
Pachytene 
Diplotene 
Meiotic arrest  
 
Fetus 
Secondary oocyte 
(Follicular growth)  
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Oocytes originate from embryonic stem cells which differentiate into primordial germ 
cells. During early fetal development in humans and ruminants, primordial germ cells 
differentiate further to oogonia which exhibit a high frequency of mitotic division. 
During this period oogonia recruit adjacent mesenchymal and surface epithelial cells 
which are the precursor granulosa cells (10, 115). Around the end of the first 
trimester, the oogonia enter meiosis, cease dividing and during preleptotene transform 
into primary oocytes. This preleptotene interphase marks the initiation of first meiotic 
prophase. At this time, the oocyte-pregranulosa cell complexes form a basement 
membrane that isolate them from adjacent oocyte-pregranulosa cell complexes 
enclosed within extensive numbers of ovigerous cords. These isolated oocyte-
pregranulosa cell complexes are referred to as primordial follicles. These primary 
oocytes in meiotic arrest will eventually progress through leptotene followed by 
zygotene and pachytene stages of the first meiotic prophase (9). However, completion 
of this first meiotic division does not occur until shortly before ovulation during adult 
life. All human oocytes within ovarian follicles during the first stages of meiosis 
contain 46 chromosomes (9). As follicles form in fetal life, ovarian follicles begin to 
grow sequentially so that during the third trimester, the ovarian cortex contains 
oogonia entering meiosis, oocyte-somatic cell complexes within ovigerous cords, 
primordial follicle formation as well as follicular growth to the early stages of antral 
growth (10). By contrast, in rodents the sequence of events is the same, except that 
follicular formation and growth does not occur until the time of birth and in the first 
few days of post-natal life. During follicular growth, the oocyte undergoes major 
changes in organelle composition and function. Also, in mice for example, oocytes 
undergo a 300 fold increase in volume, from a diameter of 12µm to about 80 µm (9, 
11).  
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1.2 (iii) Follicular growth  
As mentioned previously, follicles form as structures known as primordial 
follicles. These primordial follicles each consist of a primary oocyte surrounded by a 
single layer of flattened cells known as granulosa cells and this entity is bounded by a 
continuous basement membrane (see also Figure 1.1).  
 
Figure 1.3:- Development of ovarian follicle in a rodent (Modified from 12).  
In the rodent, the primary follicle is developmental stage 2; the preantral phases are 
stages 2-6 and the antral phase‟s stages 7-9. The blue ring immediately outside the 
granulosa cell layers represents the basement membrane (basement membrane 
surrounding primordial follicle not shown). Growing follicles also include a cell layer 
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immediately outside the basement membrane (not shown) and this cell-type is 
referred to as theca interna cells. 
The growth of primordial follicles into mature ovulatory follicles is a process 
referred to as folliculogenesis. During folliculogenesis, ovarian follicles progress 
through a series of defined developmental stages that are classified as the primary, 
secondary (pre-antral) and tertiary (antral) growth stages (12; see Figure 1.1 and 1.3). 
As follicular growth is initiated, the flattened granulosa cells become cuboidal (13) 
and proliferate by mitosis to form multiple concentric layers around the oocyte. By 
the secondary follicle stage, somatic cells immediately outside the basement 
membrane of the follicle differentiate to form cells known as theca interna. As 
increasing numbers of concentric layers of granulosa cells form, proteoglycans 
secreted from these cells lead to pockets of fluid accumulation (Figure 1.3) (14). As a 
result of these secretions, an enlarged fluid-filled space, called the antral fluid, forms 
amongst the granulosa cells. As the antrum expands, the granulosa cell layers 
immediately surrounding the egg differentiate into cumulus cells (CCs) and the cells 
lining the follicle wall develop into the mural granulosa cell (MGC) phenotype. These 
events lead to the formation of a tertiary or antral follicle.  
In humans, the progression of primordial follicles to the preantral and early 
antral stages occurs sequentially beginning in fetal life and continues throughout 
childhood, the menstrual cycle and even pregnancy until the primordial pool of 
follicles is depleted around the menopausal interval. Once follicles start to grow they 
continue to grow until they die (atresia) or ovulate (15). Thus although most follicles 
in the ovaries are present as primordial follicles, there are also numerous follicles 
present in the primary, preantral and antral growth stages (9).   
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1.2 (iv) Hormones and the regulation of ovarian follicular development 
Follicular development from primordial to the secondary stage of growth is 
essentially gonadotrophin-independent and involves enlargement of the oocyte, 
granulosa and theca cell proliferation. During preantral development, granulosa and 
theca cells acquire receptors for and develop a responsiveness to gonadotrophins but 
the presence of gonadotrophins is not essential for follicular growth at this time. 
However, from the secondary stage onwards the follicular growth becomes 
increasingly dependent upon the gonadotrophins, follicle stimulating hormone (FSH) 
and luteinising hormone (LH) (16, 17). FSH and LH are synthesized and secreted by 
the anterior pituitary gland following stimulation by gonadotrophin-releasing 
hormone (GnRH) which is, in turn, synthesised and secreted by the hypothalamus. LH 
and FSH are relatively large glycoproteins composed of a common alpha but different 
beta subunits. The alpha subunit contains 92 amino acid residues with five disulphide 
bonds and two carbohydrate moieties. The FSH beta unit is composed of 111 amino 
acids, 6 disulphide bonds and carbohydrate moieties which are N- linked at 
asparagine residue (18). LH has a beta subunit of 121 amino acids. The unique beta 
subunit of FSH and LH endows each hormone with the ability to bind its own 
receptor.   
The two distinct lineages of granulosa cells that arise during folliculogenesis, 
namely the MGC and CC, exhibit increasingly divergent responses during antral 
follicular growth and the preovulatory period. This is due to different functions 
required by these cells. The CCs become subservient to the needs of the oocyte 
whereas the MGC are more actively involved in steroidogenesis and endocrine 
signalling (19, 20). Moreover, during preovulatory development, MGC develop more 
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LH-receptors than the CC enabling the former to undergo luteinisation after ovulation 
(11, 21). Importantly during the later preantral, antral and preovulatory growth phases 
CC and MGCs acquire receptors and responsiveness to FSH (22).  
There is always a number of developing preantral and early antral follicles in 
the adult ovary. However, the development of the antral follicles to the preovulatory 
stage is critically dependent on stimulation by FSH and LH. One key role for FSH is 
to stimulate granulosa cells to stimulate aromatase (P450) enzyme synthesis. Another 
key role is to stimulate proteoglycan synthesis to enhance fluid uptake and 
enlargement of the antrum. LH and thecal cells play key roles in helping granulosa 
cells produce the steroid oestradiol (see Figure 1.4). LH acts upon the theca cells, 
stimulating them to synthesize androgens such as, androstenedione and to a lesser 
extent testosterone. The androgens are secreted into the bloodstream but they also 
diffuse across into the granulosa cells where they are converted by the aromatase 
enzyme into oestrogen (23).  
 
Figure 1.4:- Control of oestrogen secretion in the ovarian follicle 
During the initial transition of a small antral follicle into a preovulatory 
follicle, the level of oestradiol continues to increase concomitant with increasing 
numbers of both granulosa and thecal cells and an increasing sensitivity of these cells 
to FSH and LH. As a result, plasma FSH concentrations decline through the negative 
feedback effects of oestradiol on FSH release. Consequently, with declining FSH only 
Theca cells 
Synthesize androgens 
i.e. androstenedione 
LH FSH 
Granulosa cells 
Convert androgens to oestrogen 
 
Ovarian follicle 
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the largest and most responsive follicle(s) continue to be able to respond to FSH 
whereas all the smaller antral follicles are unable to maintain their growth and 
undergo atresia. Thus, the declining FSH concentrations results in only the largest 
most gonadotrophin-sensitive (i.e. dominant) follicle(s) able to survive to continue 
growth to ovulation. 
 
Figure 1.5:- Changes in hormonal concentrations and impact on follicular 
development in humans (Modified from 26)  
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In addition, during this critical period, granulosa cells in the dominant follicle acquire 
LH receptors in response to increasing responsiveness to FSH and aromatase activity. 
Thus, granulosa cells now begin to be stimulated not only by FSH but also by LH 
(24). In this way, FSH and LH have profound influences on the proportion of follicles 
which can either undergo ovulation or atresia (25). Eventually, the dominant follicle 
starts to secrete enough oestradiol to cause a significant rise in the plasma 
concentration of this steroid. In turn, this increase in plasma oestradiol exerts a 
positive-feedback effect on the pituitary release of both FSH and LH (see Figure 1.5). 
The net result is that, as the rate of follicular oestradiol secretion reaches a critical 
threshold during late follicular phase, it causes a major surge of release of LH (and 
FSH). As a consequence of this gonadotrophin surge, the oocytes resumes and 
completes its first meiotic division and also cytoplasmic maturation and an 
irrevocable chain of events is initiated that lead to follicular rupture, release of the 
matured oocyte and luteinisation of the MGC. This is followed by the formation of 
the corpus luteum (CL) and in humans an increase in both the plasma concentrations 
of progesterone and oestradiol. The CL-derived secretions of progesterone and 
oestradiol cause a decrease in secretion of gonadotrophins by the pituitary gland 
which in turn, prevents the growth of large antral follicles during the luteal phase 
(Figure 1.5). However, if pregnancy doesn‟t occur, the corpus luteum degenerates 
leading to a rise in gonadotrophin secretion and the stimulation of growth of follicles 
beyond the small antral stages. 
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1.3 Role of steroids in follicular development   
As indicated in Figure 1.5 and in the previous section, ovarian follicles 
synthesize and secrete several steroid hormones such as progestins, androgens and 
oestrogens. The major precursor is cholesterol and a key intermediatory is 
pregnenolone for the synthesis of these steroids. Progesterone is the major progestin 
produced by the ovary and is synthesised mainly by the corpus luteum and also by the 
follicular granulosa cells shortly before ovulation in some species. Androstenedione 
and testosterone are the two major androgens present in ovary. Androstenedione is a 
biologically weak androgen and a major precursor for the more potent testosterone or 
for the synthesis of oestradiol. The follicle has the highest levels of androstenedione 
and oestradiol-17β during its final stages of growth i.e. antral follicle due to the size 
of its granulosa cell population and capacity for androgen aromatisation (Figure 1.5; 
27).  
In vitro culture of mouse pre-antral follicles in presence of testosterone 
showed significant increase in follicular diameter due to more granulosa cell 
proliferation (28). By contrast when follicles were cultured with an anti-androgen or 
an androgen receptor antagonist they grew at a relatively slower rate (29, 28) whereas 
the addition of androstenedione caused an accelerated rate of growth. Mice lacking an 
androgen receptor had a reduced ovulation rate. Ovulatory genes such as HAS2 were 
not induced and as a result the COC released at ovulation had a disorganized structure, 
suggesting role of androgen receptor in ovulatory process (30). Overall, it seems 
evident that androgens play a role in regulating follicular development.  
Oestrogens act on target cells via the receptors, ERα and ERβ. Mice knockout 
studies suggest that knockout of these receptors lead to infertility in mice. ERβ 
receptor knock out mice show a partial loss of fertility due to fewer growing follicles 
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arrested in the early antral stage and the ovaries being smaller in size (31, 32). ERα 
knock out mice showed evidence of ovulation inhibition and increased proliferation of 
granulosa cells (33). Thus as with androgens, there is compelling evidence to suggest 
that oestrogen is important for normal follicular development.  
The effect of steroids on mammalian oocyte maturation has also been studied. 
It has been postulated that although the gonadotrophin-induced meiotic response of 
the mammalian oocyte is not steroid-mediated (34), that some steroids may influence 
oocyte maturation (35). Oestradiol-17β, progesterone, androstenedione and 
testosterone have all been shown to inhibit meiotic maturation in mice (35), and 
oestradiol to inhibit spontaneous maturation of porcine oocytes (36). Progesterone has 
been reported to inhibit mouse and rabbit (37) oocyte maturation, but not to affect 
maturation of human (38) or porcine oocytes (36). It remains uncertain as to whether 
the very high concentrations of steroids that may be present in follicular fluid are 
influential in effecting the bi-directional communication systems including gap 
junction functions between MGC and CC or between the CC and oocyte.  
 
1.4 Gap Junctions  
In the previous section, attention was focussed on the roles of gonadotrophin 
and steroidogenesis during follicular development. This largely involved the MGC 
and thecal cells. Here the focus is on the cell networks within the follicle including 
that for the COC. Intercellular communication is an essential aspect of ovarian 
folliculogenesis (39). The granulosa cells communicate with each other and also with 
the oocyte via a network of gap junctions (13, 40). This network of gap junctions 
unites the mural and cumulus granulosa cells with the oocyte which assists in 
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coordinating the timing of oocyte development with that of somatic cell proliferation 
and differentiation.  
During the early stages of follicular growth, signalling between developing 
oocytes and the surrounding granulosa cells is facilitated by transzonal projections 
from the granulosa cells that contact the oocyte surface (41). These projections from 
granulosa cells that traverse the zona pellucida and terminate on the oocyte cell 
surface are reported to be most abundant in preantral follicles (41). In rat, rabbit and 
sheep, the expression of gap junction genes and the presence of the proteins in 
granulosa cells and oocytes are detectable from the primary stage of follicular growth 
(McNatty & Bibby, unpublished data). It is likely that gap junctions become 
extremely important as follicles begin to form an antrum and the appearance of a 
cumulus cell phenotype becomes apparent (13). There is an increase in the size and 
number of gap junctions concurrent with granulosa cell proliferation and oocyte 
growth (42). 
Gap junctions are specialized intercellular channels responsible for the transfer 
of low molecular weight molecules between cells with intimate contact (43; see also 
Figure 1.6). The gap junction channels possess unique structures as they span the 
plasma membranes of adjacent cells. The basic unit of the gap junction is a hexameric 
structure known as a connexon. Two connexons docking end-to-end within the extra 
cellular space results in the formation of a gap junction channel (see Figure 1.6). Each 
connexon is formed by the oligomerization of the structural protein subunits, 
connexins (Cx). 
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 Figure 1.6:- Assembly of connexins, connexons, intercellular channel and gap 
junction (Adapted from 24)  
 
Connexins comprise a family of homologous membrane proteins. All 
connexins consist of four membrane-spanning domains, two extracellular loops, a 
cytoplasmic loop, and cytoplasmic N and C termini (39). The connexins oligomerize 
as a connexon, which is then transported to the plasma membrane. In turn, connexons 
from adjacent cells then interact to form the gap junctions: these cell-to-cell channels 
generally cluster in specialised regions on plasma membranes. Although there are 
many connexin (Cx) subtypes expressed in ovarian follicles, it is evident that two of 
these, Cx 43 and Cx37, are essential for ovarian follicular development (6, 45 and 46). 
Cx43 is expressed in the granulosa cells throughout folliculogenesis (6, 47) whereas 
Cx37 is found on the oocyte plama membrane within the zona pellucida (6, 39).  
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1.5 Importance of Gap junctions in follicular development 
Ovarian folliculogenesis and the production of fertilisable oocytes are 
critically dependent upon gap junctions for intercellular communication. Gap 
junctions facilitate the transfer of low MW materials (e.g. <1000mer) between cells. 
Reagents such as amino acids, inorganic ions, second messengers, nucleotides and 
glucose metabolites are amongst the materials transferred to the growing oocyte from 
gap junctions (48). Gap junctions also mediate metabolic cooperativity (46). 
Disruption of gap junctional communication can compromise the oocyte‟s ability to 
produce energy from glucose metabolites since the granulosa/cumulus cells have a 
high capacity to metabolise glucose to pyruvate and to supply the oocyte with this 
essential metabolite (49). In addition, regulatory signals for protein phosphorylation 
and dephosphorylation, and signals that control meiotic maturation are regulated by 
granulosa/cumulus cells and these regulators rely upon gap junctional communication 
for their specific targeted effects (50).  
The importance of gap junctional intercellular communication has been 
established in connexin knockout mice. Mice lacking Cx37 as a result of targeted 
mutation in the Cx37 gene show arrested folliculogenesis and lack mature follicles 
(45). Oocyte development arrests before meiotic competence is achieved and follicles 
fail to ovulate (45). These results demonstrate that gap junctional communication 
influences the acquisition of meiotic competence by the oocyte and provides evidence 
that gap junctions play essential roles in folliculogenesis and oogenesis.  
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1.6 Oocyte Maturation  
In mammals, the first meiotic division is initiated during fetal life and 
proceeds up to the diplotene stage of the first prophase (51, 52, and 53). Oocyte 
growth occurs concomitantly with follicle growth, but the oocyte remains arrested at 
prophase I until a preovulatory surge of LH from the pituitary stimulates meiotic 
resumption. The fully grown immature oocyte then resumes meiosis, progressing 
from prophase of the first meiotic division to metaphase of the second meiotic 
division, where it becomes arrested again. The progression from prophase I to 
metaphase II is termed oocyte maturation and is a process that includes nuclear as 
well as cytoplasmic changes that allow the mature egg to be fertilized (53, 54). Only 
oocytes that have been meiotically matured are capable of being fertilized and 
undergo development normally (53).  
The first structural change that is evident during the resumption of meiosis in 
oocytes is germinal vesicle breakdown (GVBD) (11, 51). GVBD is followed by 
chromosome condensation and spindle formation. Separation of homologous 
chromosomes then occurs, together with asymmetric cleavage of oocyte cytoplasm.  
Further progression of oocytes from metaphase II requires fertilization.   
During follicular growth, oocytes remain in diplotene stage and are 
incompetent to resume meiosis. The acquisition of meiotic competence occurs during 
oocyte growth and during the transition from preantral to antral stage; oocytes become 
increasingly competent (55; see Figure 1.7). In humans, ruminants and rodents, 
oocytes acquire full meiotic competence and attain full size during the final phases of 
the menstrual and oestrous cycles respectively.  
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Figure 1.7:- Acquisition of meiotic competence during follicular growth (Modified 
from 56) 
It has been observed that when meiotically-arrested oocytes are removed from 
the ovarian antral follicles they spontaneously resume meiosis, suggesting that the 
follicular microenvironment maintains the oocyte in meiotic arrest (57). In vivo, it has 
been well established that in preovulatory follicles, LH induces a sequence of events 
leading to the resumption of oocyte maturation (11, 16, and 54). Since LH receptors 
are located on the mural granulosa cells, but not cumulus cells or the oocyte, the 
mechanism by which LH stimulates oocyte maturation is indirect (58). It has been 
hypothesized that LH acts in either removing an inhibitory, maturation arresting 
substance or it could provide a positive, maturation-promoting substance to the oocyte 
(51, 52). Among the various explanations as to how LH triggers meiotic resumption, 
one is that LH causes gap junction degradation which in turn results in reduction in 
the transfer of meiosis-arresting substances from granulosa and cumulus cells to the 
oocyte. Hypoxanthine has been shown to be a factor capable of inhibiting meiotic 
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resumption and is present in follicular fluid of rodents at concentrations of ~2-4mM 
(59). In the absence of hypoxanthine, meiotically competent oocytes underwent 
spontaneous GVBD in vitro whereas in the presence of hypoxanthine 95% of 
competent oocytes were maintained in meiotic arrest (59). Cyclic adenosine 3,5 -
monophosphate (cAMP) also functions as an inhibitory signal produced by granulosa 
and cumulus cells that is transferred to the oocyte through gap junctions (60).  
Another hypothesis is that LH doesn‟t induce sufficient degradation of gap 
junctions per se but induces a positive signal from granulosa cells to the oocyte to 
override the inhibitory effects of cAMP, to promote meiotic resumption (52). The 
sterol, follicular fluid–meiosis-activating sterol (4,4-dimethyl-5a-cholesta 8,14,24-
trien-3b-ol; FF-MAS), is a candidate oocyte maturation-inducing substance (52, 61). 
FF-MAS stimulate the resumption of meiosis in isolated oocytes of various 
mammalian species including mouse, rat, and human (61). Calcium also plays a role 
in providing a positive signal, since LH causes an increase in calcium in granulosa 
cells and this increased level of calcium in oocytes may cause GVBD (62, 63).  
Irrespective of the mechanisms involved it is clear that the loss of gap 
junctional communication between granulosa and cumulus cells and the oocyte is 
associated with the resumption of meiosis (64, 65). The loss of gap junctions between 
the cumulus cells and the oocyte will inevitably lead to a reduction in the transfer of 
meiotic inhibitory substances from follicle cells to oocyte. Just prior to ovulation, 
there is a significant decrease in the number of gap junctions as well as a decrease in 
the extent of ionic coupling (6, 65, 66). Ionic coupling and transfer of molecules are 
maximal before the preovulatory surge and decreased afterwards (67).  In this context, 
LH has been shown to decrease gap junctional permeability between follicular cells, 
before GVBD (68).  
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1.7 Regulation of Oocyte maturation  
When mammalian COC are recovered from antral follicles and cultured in 
vitro, they spontaneously undergo meiotic maturation. As mentioned earlier, the 
follicular microenvironment prevents this premature maturation. It is likely that the 
recovery of COC from the follicular microenvironment disrupts the extent and 
viability of gap junctions formerly present between MGC and CC but also between 
the CC and between the CC and oocyte.  This process of recovery of COC and 
separation from MGC is likely to cause a loss of cAMP synthesis and thus a reduction 
in delivery of this factor to oocytes.   
 
1.7 (i) cAMP  
The level of cAMP in tissues or biological fluids is regulated by two major 
enzymes; adenylate cyclase (AC) and phosphodiesterase (PDE) that respectively 
catalyze the synthesis and degradation of cAMP respectively. Adenylate cyclase 
catalyzes the conversion of ATP to 3', 5'-cyclic AMP (cAMP) and pyrophosphate. 
The resulting cAMP acts as a second messenger by interacting with and regulating 
other proteins such as protein kinase A (PKA) and cyclic nucleotide-gated ion 
channels. Cyclic AMP acts by activating the cellular type I and II PKA pathways and 
in turn the timing of oocyte meiotic maturation (59).  
Cyclic AMP can be generated within the oocyte and/or transferred to the 
oocyte from the CC via gap junctions (67). The evidence suggests that the CC are the 
major contributor to the total cAMP content of the oocyte and thus cAMP within the 
oocyte is maintained at high levels through transfer from somatic cells. As mentioned 
earlier, high levels of cAMP have shown to prevent meiotic resumption (70, 71). The 
high levels of cAMP maintain PKA in an active state which causes phosphorylation 
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of protein substrates. These phosphorylations are inhibitory to oocyte maturation. A 
fall in intracellular cAMP levels signals reentry of the oocytes into meiotic 
progression and a decrease in cAMP levels of the oocyte occurs just before GVBD in 
vivo and in vitro (72, 73). Under low cAMP conditions, the oocyte phosphoproteins 
would be dephosphorylated and meiotic maturation would be initiated.   
Therefore, it is likely that cAMP is continuously transferred to the oocytes to 
maintain meiotic arrest. However, during the LH surge, the resulting high cAMP 
levels in mural granulosa cells induces a major differentiative change in these cells 
resulting in luteinization and a concomitant loss of gap junctions with cumulus cells 
(74). In turn, the high intrafollicular gonadotrophin levels, probably of FSH, results in 
high CC cAMP levels leading to CC expansion due to a change in proteoglycan 
synthesis and an associated loss of gap junctions and therefore the uninterrupted flow 
of cAMP to the oocyte is compromised (6, 71).  
 
1.7 (ii) Phosphodiesterases  
Phosphodiesterases (PDE) are enzymes that degrade cAMP. They act by 
hydrolysing the bond between the phosphate and the 3-hydroxyl group of the ribose 
sugar in cAMP. Different types of PDEs control cAMP levels in the granulosa cells 
and oocyte and play essential roles in the control of meiosis. In mammals, PDE4 gene 
expression is specific for the follicular cells such as mural granulosa and cumulus 
cells, whereas the PDE3 gene is expressed primarily in the oocytes (75). Recently, the 
use of PDE inhibitors has demonstrated the essential role of PDEs in regulating 
meiotic arrest (75, 76). PDE inhibitors prevent cAMP degradation resulting in the 
accumulation of cAMP, which in turn maintains meiotic arrest. Inhibitors selective for 
PDE3 were most effective inhibitors of GVBD suggesting that PDE3 activity is 
 32 
necessary for resumption of meiosis or oocyte maturation both in vitro and in vivo 
(75, 76).  
 
1.8 Oocyte-Somatic cell interactions: role of GDF9 and BMP 15 
Bi-directional communication between the oocyte and somatic cells plays an 
important role during folliculogenesis (Figure 1.8). Granulosa and cumulus cells assist 
oocyte growth and development by influencing nutrient and energy availability and 
promoting meiotic arrest and maturation as outlined earlier.  
 
Figure 1.8:- Bi directional communication between the oocyte and its granulosa cells 
(adapted from 11). The Oocyte (O) secretes paracrine factors that influence adjacent 
somatic cell proliferation and differentiation.  
 
In turn, the growth and differentiation of follicular somatic cells is critically 
dependent upon oocyte paracrine signalling. The oocyte promotes follicular growth 
and somatic cell differentiation via the secretion of paracrine factors such as growth 
differentiating factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) (78). 
Metabolism 
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Meiotic arrest 
Maturation 
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GDF9 and BMP15 are members of the Transforming Growth factor β (TGF β) family 
of proteins. The amino acid sequence of mouse GDF9 contains four N- linked 
glycosylation sites, one of which is in mature region, whereas mouse BMP15 contains 
five N- linked glycosylation sites, two of which are in the mature region (79, 80). The 
GDF9 mature region is comparatively conserved as opposed to BMP15 mature 
region, which diverges greatly among species. Within the ovary, the oocyte is the site 
of GDF9 and BMP15 gene expression (81).  
GDF9 and BMP15 have been found to play important roles in fertility; 
however the relative importance of them differs among species. GDF9 knockout mice 
showed cessation of follicular development and were infertile due to impaired 
granulosa cell proliferation (82); however, BMP15 knockout mice did not have 
arrested follicular growth suggesting that BMP15 doesn‟t play part in normal 
follicular development in this species (83). Naturally occurring mutations of BMP15 
or GDF9 in sheep resulted in infertility due to an inhibition of normal follicular 
growth from the primary follicle stage (84). This suggested that BMP15 and GDF9 
are both critical for follicular development and fertility in sheep. Also, it‟s worth 
noting that naturally-occuring genetic mutations in BMP15 in women also results in 
an absence of normal follicular development and primary ammenorhoea (85).  
In addition to GDF9 being essential for follicular growth, it is also important 
for the development of the cumulus cell phenotype (81, 82). Recombinant GDF9 
enhances the growth of preantral follicles isolated from immature rats and also 
promotes proliferation of granulosa cells (86) by increasing DNA synthesis. Also, as 
the oocyte grows, the secretion of GDF9 stimulates granulosa cells to secrete the 
growth factor kit-ligand. In turn, kit ligand interacts with the kit receptor on the 
 34 
oocyte to promote oocyte growth until it becomes mature, where GDF9 then 
suppresses kit ligand expression on granulosa cells hence ceasing oocyte growth (87).  
These oocyte secreted factors are mitogenic promoting both MGC and CC DNA 
synthesis and they either indivually or collectively regulate ganulosa/cumulus cell 
differentiation (78). CC differ from MGC as they have very low LHR expression, 
high proliferation rate and can undergo expansion. GDF9 suppresses luteinizing 
hormone receptor expression on CCs and regulates steroidogenesis in these cells by 
inhibiting luteinisation (81, 86). Hence the oocyte maintains the distinct CC 
phenotype via the secretion of GDF9, while the MGC some distance away from the 
oocyte and thus exposed to a lower concentration of GDF9 are thought to be inhibited 
sufficiently not to luteinise during follicular growth but not enough to inhibit the 
expression of the LHR.  
BMP15 can also inhibit progesterone synthesis by granulosa cells in vitro (88) 
and as progesterone is an indicator of cellular luteinisation, it shows that BMP15 and 
GDF9 can both act as luteinisation inhibitors during follicular development. While 
there is strong evidence to indicate that GDF9 is synthesized and secreted to act in a 
paracrine manner with the developing follicle, it remains uncertain, in rodents at least, 
as to whether BMP15 protein is secreted in rodents before the preovulatory LH surge 
(88). 
After the preovulatory gonadotrophin surge, in rodents, GDF9 and BMP15 
play vital roles in the preovulatory follicle by enabling CC expansion in part by  up 
regulating the genes encoding hyaluronan synthase 2 in CC (78). In sheep, these 
factors have been shown to be critical for ovulation and the formation of normal 
functioning corpora luteum (81). Hence BMP15 and GDF9 play dominant roles in 
female fertility in a species dependent manner.  
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1.9 Mimicking the follicular microenvironment: effect of Milrinone, Forskolin, 
FSH and IGF1 
The follicular microenvironment is crucial for the attainment of developmental 
competence in oocytes, and it is an utmost requirement for the in vitro maturation of 
oocytes to have similar follicular environment conditions. As discussed earlier, the 
approach to delay spontaneous meiotic maturation in vitro allows complete 
cytoplasmic maturation and attainment of development competence.  
In rats, selective inhibition of PDE3 blocks meiotic resumption without 
affecting ovulation (77). PDE inhibitors can be classified on the basis of specificity 
for different PDE‟s that are compartmentalized either within somatic cells i.e. PDE4 
or the oocyte i.e. PDE3. Milrinone inhibits the PDE3 enzyme in the oocyte, rolipram 
inhibits PDE4 enzyme in granulosa cells and IBMX is a non-selective PDE inhibitor 
(75, 76). It has been reported that inhibition of PDE3 enzyme by milrinone causes a 
delay in oocyte meiotic maturation which was characterised by GVBD (75). 
Milrinone prevents cAMP degradation by PDEs causing intracellular cAMP 
accumulation in mammalian oocyte. On the other hand, rolipram is ineffective in 
preventing GVBD, instead it promotes oocyte maturation (75). It has been suggested 
that PDE4 is essential for normal ovulation and in PDE4 null mice, the follicles fail to 
reach pre-ovulatory stage due to premature luteinization (89). The lack of PDE4 
causes accumulation of cAMP in granulosa cells leading to premature luteinzation 
and entrapment of oocytes in immature luteinized follicles (89). Also inhibition of 
PDE4 in granulosa cells results in activation of protein kinase II (PKAII), whose 
activation causes GVBD (90). These results emphasize that the selective inhibition of 
oocyte PDE3 by milrinone can control oocyte maturation.  
As mentioned earlier, high levels of cAMP in the oocyte is important with 
respect to maintenance of meiotic arrest. Forskolin stimulates cAMP production by 
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activating adenyl cyclase very rapidly and reversibly (91). It is a plant derivative and 
has a diterpene structure as shown in Figure 1.9.  
 
Figure 1.9:- Forskolin, a diterpene produced by Coleus forskohlii (Adapted from 91) 
 
It has been demonstrated that forskolin inhibits spontaneous maturation of rat 
oocytes in vitro (6, 92). The effect of FSH on the oocyte is mediated through the 
surrounding somatic cells. It stimulates somatic cells to produce factors that are 
important for the completion of oocyte growth and maturation, both in vitro and in 
vivo. FSH is the major factor contributing towards antral follicle growth in vivo and is 
essential to achieve developmentally competent oocytes in vitro (93). FSH triggers 
granulosa cell proliferation, prevents atresia, induces synthesis of luteinizing hormone 
receptors on mural granulosa cells and promotes steroid expression in vivo (93). FSH 
causes cAMP synthesis as it activates membrane receptors and G proteins of 
granulosa cells which inturn activate adenyl cyclase leading to cAMP production (56). 
There is evidence that in defined conditions, FSH enhances the ability of the oocyte to 
reach the blastocyst stage after fertilization in mice and has been shown to improve 
embryonic development (94).  
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Insulin-like growth factor-1 (IGF-1) is secreted from somatic cells in response 
to gonadotrophins. IGF1 binds to the extracellular domain of a membrane- bound 
receptor 1(IGFR1) which forms a tetramer structure composed of two α subunits and 
two β subunits that are linked by interchain disulphide bonds (95). An important 
action of IGF1 is to enhance the action of FSH or LH on ovarian follicular 
development. IGF1 enhances FSH-induced granulosa cell proliferation and 
differentiation by stimulating proteoglycan production which causes antrum 
formation, in pre-antral rat follicles. It enhances FSH-induced aromatase activity 
which in turn promotes androgen production in theca cells and also enhances LHR 
expression (96, 97). Studies on pre-antral rat follicles cultured with IGF1 show an 
increased number of gap junctions between oocytes and granulosa cells, suggesting 
that IGF1 assists in follicular development by promoting gap junctions within the rat 
pre-antral follicles (98). Furthermore, the addition of IGF-1 to the culture medium 
increases the in vitro nuclear maturation rate in rabbits (99).  
 
1.10 The rat oestrous cycle 
The present study utilizes rats as the animal model therefore it is of value to 
outline the physiological events that regulate the rat oestrous cycle. The oestrous 
cycle of the rat is divided into four stages: pro-oestrus, oestrus, metoestrus and 
dioestrus. In the pro-oestrus stage the ovarian follicles develop towards the 
preovulatory stage and an increasing endometrial activity occurs at this stage. During 
the oestrous stage, the preovulatory follicles secrete high levels of oestradiol leading 
to ovulation and the development of the corpus luteum from the ovulated follicle 
starts in metoestrus cycle and release of oestrogen from the ovary is inhibited. 
Throughout the dioestrus phase, development of corpus luteum continues and 
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progesterone is released. Follicle growth increases more than 8 fold as it reaches early 
oestrous stage. Rats undergo regular oestrous cycles throughout the year and are poly-
oestrous.  
 
1.11 Aim of study  
The primary aim of this study was to investigate the effects of various steroids, 
growth factors and cAMP stimulators on gap junction activity in oocyte-cumulus cell 
complexes. It was hypothesized that factors present within the microenvironment of 
the developing antral follicle such as steroids, growth factors or cAMP stimulators, 
influence the rate of transfer of low molecular weight compounds from the cumulus 
cells to the oocyte.  
To address this aim, a gap junction assay was developed in which the cumulus-
oocyte complexes were recovered from their follicular environment and the transfer of 
the fluorescent compound, Calcein-acetoxymethyl (Calcein-AM), from cumulus cells 
into the oocyte was used as a measure of gap junction activity. Calcein AM is a non-
fluorescent, hydrophobic compound that easily permeates through cumulus cells. 
Endogenous esterases within cumulus cells cleave the acetoxy methyl (AM) group 
producing the green fluorescent calcein, a hydrophilic strongly fluorescent compound 
that is well-retained in the cell cytoplasm and is non toxic to cells. In this study, the 
gap junction activity was assessed in COC recovered from rat antral follicle. The gap 
junction activity was observed within COCs obtained from sexually immature 21-25 
day old Sprague-Dawley rats without any hormonal treatments. The second aim of 
this study was to use a PCR technique to measure Cx37 and Cx43 expression levels in 
oocytes and cumulus cells respectively following exposure of COC to one of the test 
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reagents that was shown to alter the transfer rate of Calcein from cumulus cells to the 
oocyte. 
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MATERIALS AND METHODS 
 
2.1 Media composition: 
2.1a Dissection medium 
L-15 Lebowitz solution (Invitrogen; cat# 11415-114; for address of companies 
refer to Appendix 1) containing phenol red and L-glutamine, supplemented with 0.1% 
BSA (w/v: ICP Bio Ltd.), 100 IU Penstrep (Invitrogen) and 15mM Hepes buffer 
(Sigma-Aldrich) was used as the dissection medium. Milrinone (100µM; Sigma-
Aldrich) was added to the stock dissection medium before use.  
 
2.1b Incubation media 
Phenol red-free Medium199 (M199) (Invitrogen; cat# 11150-059) containing 
L-glutamine, 2.2g/L Sodium bicarbonate and Earle‟s salts was supplemented with 
0.3mg/ml Polyvinyl alcohol (PVA) and was used as incubation medium. Milrinone 
(100µM) was added to the stock incubation medium before use.  
 
2.1c Wash media 
The wash medium consisted of Phenol red-free M199 supplemented with 100 
IU Penstrep and 0.1% BSA. Milrinone (100µM) was added to the stock wash medium 
before use.  
 
2.2 Stock solutions  
The phosphodiesterase inhibitor, Milrinone was dissolved in DMSO and made 
up in phenol red-free M199 at a concentration of 1mM and stored at -20ºC. The 
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fluorescent dye Calcein-AM (Invitrogen; cat# c1430), which was used to measure gap 
junction activity, was stored in DMSO at a concentration of 1mM at -20ºC. The 
cAMP stimulator, Forskolin (Sigma-Aldrich) was dissolved in absolute ethanol at a 
concentration of 1mM and stored at -20ºC. Insulin like Growth Factor (IGF1) 
(Novozymes) was made up in M199 at a concentration of 1ng/µl and stored at 4ºC. 
Recombinant human-Follicle Stimulating Hormone (Rh-FSH) (Prospec) was prepared 
at a concentration of 150mIU/µl in M199 containing 0.1% BSA, and stored at -20ºC. 
Dibutryl cyclic AMP (dcAMP; Sigma-Aldrich) was dissolved in M199 at a 
concentration of 100µM. Steroids such as oestradiol, testosterone, androstenedione 
and progestrone (Sigma-Aldrich) were prepared and stored at 4ºC. Stock solutions of 
oestradiol (100µg/ml in absolute ethanol), testosterone (100µg/ml in absolute 
methanol), progesterone (100µg/ml in absolute ethanol) and androstenedione 
(100µg/ml in absolute ethanol) were prepared and stored at 4ºC. The control solutions 
of absolute ethanol and methanol were also stored at 4ºC. 
 
2.3 Microscopy 
For ovarian dissections and collection of COCs, a Ziess stereo-zoom 
dissection microscope (475265, West Germany) was used. The intensity of 
fluorescence within denuded oocytes was measured using a Leica inverted 
fluorescence microscope (CTR4000; Albany 0751, New Zealand) fitted with a 
CRAIC technology fluorescence detection system. The fluorescence recordings were 
captured using the CRAIC technology software and saved on hard drive. The 
fluorescent settings on the detection system were 50 millisecond recordings over the 
wavelengths 300-700nm.  
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2.4 Ovaries 
The ovaries were obtained from 21-25 day old sexually immature Sprague-
Dawley rats provided by the Department of Psychology, Victoria University of 
Wellington. The ovaries were obtained on my behalf by Ms Norma Hudson (School 
of Biological Sciences) from female rats that were being culled from the breeding 
colony. Rats were housed in a temperature-controlled room with food and water 
provided ad libitum. Animals were sacrificed using Carbon dioxide.  
 
2.5 Storage of ovaries before dissections 
Ovaries were removed and collected into 1ml of Dissection media containing 
milrinone (100µM), and were stored in a 37ºC water bath until further use. COCs 
were isolated from the ovarian follicles within 2 hours of ovary collection.  
 
2.6 Isolation of cumulus-oocyte complexes  
 Ovaries submerged in dissection media were cleaned of their surrounding fat 
layer using dissecting scissors and forceps under the dissecting microscope. To isolate 
COCs, antral follicles (~0.5-1mm diameter) visible on the ovarian surface were 
punctured using a 20 gauge needle to recover the COC. Approximately 60 COCs were 
recovered from each pair of ovaries. All COCs collected were examined under the 
microscope and those selected for further study were those with two or more intact 
layers of cumulus cells surrounding the oocyte. Selected COCs were then transferred 
to either a 48-well plate for performance of a gap junction assay or to a culture dish 
for preparation for QPCR analysis. 
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2.7(i) Gap Junction Assay: Effect of time 
After isolation, a minimum of 10 COCs were transferred into each of six wells 
(T0, 60, 120, 180, 240 and 360 minutes) containing of 200µl wash media 
supplemented with milrinone (100µM) in a 48-well plate. Each well represented the 
time interval after which gap junction activity was measured. Care was taken to 
ensure that the amount of dissection media transferred with the COC was negligible, 
since phenol red is known to interfere with the fluorescence readings of calcein. To 
remove any excess phenol red media, this wash step was repeated twice by 
transferring COCs into new wells containing fresh wash media (200µl) containing 
milrinone (100µM). All COCs were then transferred into new wells containing 200µl 
incubation media supplemented with  milrinone and pulsed with calcein-AM dye 
(1µM) for 10 minutes in a 37ºC  CO2 (5%) incubator at 96% humidity. Thereafter, 
COCs were transferred into new wells containing fresh incubation media (200µl) 
supplemented with milrinone. After the respective incubation times (ie 0, 60, 120, 
180, 240 and 360 minutes), COCs were washed twice in 200µl incubation media 
containing milrinone and were transferred to an eppendorf tube. Oocytes were then 
denuded of their surrounding cumulus cells by vigorous vortexing for 5 minutes. The 
fluorescence intensities of the denuded oocytes were then measured using the CRAIC 
fluorescence system. 
 
2.7(ii) Gap Junction Assay: Effect of Treatments 
The effect of different treatments on the amount of dye (Calcein) transfer from 
the cumulus cells to the oocyte was also examined using the gap junction assay. The 
various concentrations of treatments used are illustrated in Table 2.1. Appropriate 
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controls were used in all experiments, i.e. if a solvent was used to prepare the 
treatment stock solution; the solvent was added to the media in the control wells. 
COCs were examined at time 0 (T0) to provide a zero time reference point and after 
240 min (T240) of exposure to different treatments and also for the controls.  
After isolation, a minimum of 10 COCs were transferred into each of four 
wells (Control T0; Control T240; Treatment T0 and Treatment T240) containing 
200µl of wash media supplemented with 100µM milrinone in a 48-well plate. Care 
was taken to ensure that the amount of dissection media transferred with the COC was 
minimal. This wash step was repeated twice. All COCs were then transferred into new 
wells containing 200µl of incubation media supplemented with 100µM milrinone, and 
pulsed with 1µM calcein-AM dye for 10 minutes by placing the plate in a 37ºC 
incubator gassed with 5% CO2 and held at 96% humidity. Thereafter, COCs from all 
wells were transferred into new wells containing either 200µl of incubation media 
supplemented with milrinone and the appropriate solvent (only if it was used to 
prepare treatment in question); or 200µl of incubation media supplemented with 
milrinone and the appropriate treatment (refer to Table 2.1) and returned to a 37ºC 
incubator gassed with 5% CO2 and held at 96% humidity. After the respective 
incubation times (i.e. 0 and 240 minutes), COCs were washed twice in 200µl of 
incubation media containing milrinone and transferred to an eppendorf tube. Oocytes 
were denuded of their surrounding cumulus cells by vigorous vortexing for 5 minutes. 
The fluorescence intensities of the denuded oocytes were measured using the CRAIC 
fluorescence system.  
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      Treatment                                              Concentration 
  
Oestradiol  1µg/ml 
Testosterone  1µg/ml 
Progesterone 1µg/ml 
Androstenedione 1µg/ml 
IGF1 10ng/ml 
Forskolin 10-5M/ml 
Rh-FSH 50mIU 
dcAMP 1µM 
Oestradiol+ Forskolin 1µg/ml + 10-5M/ml 
Testosterone+ Forskolin 1µg/ml + 10-5M/ml  
Androstenedione + Forskolin 1µg/ml + 10-5M/ml 
Oestradiol+ Forskolin+ IGF1 1µg/ml + 10-5M/ml+10ng/ml 
Testosterone+ Forskolin+ IGF1 1µg/ml + 10-5M/ml+10ng/ml 
 
Table 2.1:- The different treatments and respective concentrations used in the gap 
junction assay 
 
2.8 Quantitative PCR (QPCR) 
QPCR was employed to analyse changes in the gene expression of Cx37 and 
Cx43 present in oocytes and cumulus cells, respectively after exposure to no 
treatment or forskolin. The QPCR method was validated previously by Dr Janet 
Crawford (School of Biological Sciences).  
 
2.8(i) Collection of COC samples for QPCR 
After isolation, approximately 30-35 COCs were selected and transferred into 
a clean culture dish containing 2000µl of wash media supplemented with 100µM 
milrinone. This wash step was repeated twice and the COCs were then transferred into 
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respective culture dishes (with or without treatment), with a minimum of 7-8 COCs in 
each dish. The culture dish with treatment contained 2000µl of incubation media 
supplemented with 100µM milrinone and 10
-5
 M/ml Forskolin or vehicle (i.e ethanol). 
The culture dishes were kept in the incubator gassed with 5% CO2 and held at 96% 
humidity and after the respective incubation times (i.e. 0 and 240 minutes), each 
individual COC was washed in phosphate buffered saline (PBS) supplemented with 
milrinone, so that one COC was present in each well of a 96-well plate. Thereafter, 
each individual COC in a volume of 5µl was transferred into a sterile eppendorf tube 
on dry ice and then stored at -80ºC until QPCR analysis.  
 
2.8(ii) ArrayPure Nano-scale RNA extraction  
Total RNA (tRNA) was extracted from COCs using reagents provided in the 
ArrayPure purification kit (Epicentre; cat# MPS04050) and following manufacturer‟s 
instructions.  
For logistical purposes, RNA was extracted from 10 samples at a time. 
Samples were thawed, vortexed and briefly centrifuged. A pre-mix solution of 10µl of 
Proteinase K solution (5µg/µl) in 300µl of Nano-scale Lysis solution was prepared on 
ice. To each sample, 30µl of this premix solution was added and the samples were 
mixed thoroughly by vortexing for 1 minute followed by incubation at 67ºC in a water 
bath for 15 minutes. The lysed samples were then placed on ice for 5 minutes, after 
which 18µl of MPC Protein Precipitation Reagent was added and samples were 
vortexed briefly. The precipitate was pelleted by centrifugation for 7 minutes at 4ºC at 
12000g and the supernatant was transferred to clean eppendorf tube. The tRNA was 
precipitated by the addition of 50µl of absolute isopropanol (Sigma-Aldrich) and then 
centrifugation for 5 minutes at 4ºC at 12000g. All of the residual isopropanol was 
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removed using a pipette and the pellet was air-dried for 5 minutes. Meanwhile, a pre-
mix solution of 5µl of RNase-free DNase I in 200µl of 1 x DNase Buffer was 
prepared on ice and 20µl was added to each tRNA pellet for resuspension. Samples 
were then vortexed for 1 minute followed by incubation at 37 ºC in a water bath for 
30 minutes to ensure all contaminating DNA is removed. After incubation, 20µl of 2x 
Nano-scale lysis solution and 20µl MPC Protein Precipitation Reagent were added to 
the samples and were mixed by vortexing briefly after the addition of each reagent. 
The precipitate was pelleted by centrifugation for 5 minutes at 4ºC at 12000g. On ice, 
the supernatant containing the tRNA was transferred into sterile eppendorf tubes. The 
tRNA was precipitated by addition of 50µl isopropanol and centrifuged for 5 minutes 
at 4ºC at 12000 x g. The isopropanol was aspirated and the pellet was washed by the 
addition of 50µl of 70% ethanol and centrifuged at 12000 x g for 3 minutes. All the 
residual ethanol was removed using a pipette and the pellet was air dried for 5 
minutes. The purified tRNA was resuspended in 10µl Ultra-Pure distilled water. All 
samples were then incubated at 56ºC for 2 minutes, vortexed for 1 minute and stored 
at -80ºC.  
 
2.8(iii) Reverse Transcription PCR  
Complementary DNA (cDNA) was synthesised using the reagents provided in 
the SuperScript VILO kit (Invitrogen cat # 11754-250) and following manufacturer‟s 
instructions.  
This kit consisted of a 10X SuperScript Enzyme mix and a 5X VILO Reaction 
mix. The 10X SuperScript Enzyme mix comprised an RNaseOUT Recombinant 
Ribonuclease inhibitor, a proprietary helper protein and SuperScript III RT enzyme, 
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which had reduced RNase activity and an increased thermal stability. The 5X VILO 
Reaction mix contained random primers, MgCl2 and dNTPs in a buffer.  
For logistical purposes, Reverse Transcription PCR was performed for 20 tRNA 
samples at a time. The tRNA samples were thawed, vortexed and briefly centrifuged. 
A pre-mix solution of 4µl of 5X VILO Reaction mix, 2µl of 10X SuperScript enzyme 
mix and 4µl of Ultra Pure distilled water were prepared for each set of samples. To 
each Corbett 0.2ml PCR tube (Corbett Research) on ice, an aliquot of 10µl of this pre-
mix solution was added to 10µl of tRNA for a total volume of 20µl. Care was taken to 
ensure that the RNA was well mixed with the premix reagents by vortexing all tubes 
briefly. Samples were then placed in a Rotor-Gene 6000 Rotary Analyser (Corbett 
Research; model# RG6000) under the following conditions: 25ºC for 10 minutes, 
42ºC for 120 minutes and the reaction was terminated by 85ºC for 5 minutes. The 
cDNA samples were stored at -20ºC until further analysis using QPCR. 
 
 
2.8(iv) Quantitative PCR  
QPCR reactions were carried out using Brilliant Multiplex QPCR Master mix 
(Stratagene; cat # 600553) as it provided all the buffer components in a preoptimized 
solution. It also contained SureStart Taq DNA polymerase with hot start capability 
and 5mM of MgCl2.  
Specific forward and reverse primers, and Taqman probes were designed for 
each gene of interest (i.e. Cx37 and Cx43) and the housekeeping gene (RPL19) using 
the computer package „Beacon Designer‟ (premier Biosoft International, Palo Alto, 
CA, USA) by Dr Janet Crawford (School of Biological Sciences) (Refer to Table 2.2, 
2.3). 
 49 
 
Gene Primer sequence (5‟-3‟) Molecular %GC 
  Weight 
  (µg/µmole) 
Cx37-Forward GACGGTCGTCTTCGCATTCG 6423 60 
Cx37-Reverse ACGCCACTGGCCATAGAGG 6128.8 63 
Cx43-Forward AGACTGCGGATCTCCAAAATACG 7415.6 47 
Cx43-Reverse CTTGTTGTAATTGCGGCACGAG 7138.4 50   
RPL19-Forward GACCCCAATGAAACCAACGAAATC 7683.8 45 
RPL19-Reverse GGAATGGACAGTCACAGGCTTC 7141.4  54 
 
Table2.2:- Sequences of forward and reverse primers specific for Cx37, Cx43 and 
RPL19 genes 
 
 
Gene                 Probe sequence (5‟-3‟)                      
    
Cx37   [6FAM] CCTCCAGCACACTCTTACACAGCACACTG [BHQ1] 
Cx43  [HEX] CCTCACCAACGGCTCCACTCTCGC [BHQ1] 
RPL19  [Cy5] CCAATGCCAACTCTCGTCAACAGATCAGGAAG [BHQ3] 
 
Table2.3:- Taqman probes contained a fluorophore located at the 5‟ end and a 
quencher (Black Hole Quencher; BHQ) on the 3‟ end. 
 
For logistical purposes, QPCR was performed for 30 samples at a time and 
were repeated once to give two technical replicates. All samples were in duplicate, 
and a positive control (rat calibrator) and negative control (no template control) were 
included in each run.  
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The cDNA samples were thawed, vortexed and centrifuged briefly. In a single 
reaction, 12.5µl of 2x Brilliant Multiplex QPCR mastermix, primers and probes at the 
appropriate concentrations (refer to Table 2.4); 1.5µl of cDNA and Ultra-Pure 
distilled water to adjust the final volume to 25µl was added into Corbett 0.1mL strip 
tubes (Corbett Research).  
 
Primer/Probe    Final Concentration (nM) 
Cx37-Forward    300 
Cx37-Reverse    100 
Cx37-Probe    50 
Cx43-Forward    100 
Cx43-Reverse    100 
Cx43-Probe    50 
RPL19-Forward   200 
RPL19-Reverse   200 
RPL19-Probe    50 
 
Table2.4:- Concentration of primers and probes required for QPCR 
 
The tubes were sealed with strip caps (Corbett Research) and subjected to the 
following conditions: 95ºC for 10 minutes followed by 40 cycles of 95ºC for 15 
seconds and 60ºC for 1 minute in a Rotor-gene 6000 rotary analyser (Corbett 
Research; model# RG6000).  
The PCR program generated amplification plots and provided CT values 
representing gene expression due to different treatments. The CT value refers to the 
first cycle at which it is possible to distinguish the amplification generated 
fluorescence as being above the background signal. From the CT value, dCT; ddCT 
and 2
(-ddCT)
 values were calculated. The 2
(-ddCT)
 values were subjected to statistical 
analysis and results were analysed.  
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2.9 Statistical Analyses 
In the gap junction assay, the fluorescence intensity within each oocyte was measured 
using a fluorescence spectrophotometer. The fluorescent readings of individual oocytes 
measured for each treatment were averaged to calculate the mean fluorescent intensity. 
One way analysis of variance (ANOVA) and the Dunnett test  was performed using SPSS 
16.0 on the data obtained for testing the effect of incubation time relative to time 0. The 
unpaired student‟s t test on non-transformed data was performed using the statistics 
program SPSS 16.0 when comparing the control versus treatment groups at times 0 and 
after 240 mins for the COCs treated with E; T; IGF1; F; T+F; E+F; E+F+IGF1; 
T+F+IGF1; P; A; A+F; dcAMP and FSH. For other treatment comparisons at 0 and 240 
mins, the Levene‟s test for homogeneity of variances revealed that the data for forskolin; 
dcAMP; FSH; T+F; E+F+IGF1 and A+F treatment groups had significantly different 
variances. Consequently, the data obtained from these treatment groups were Ln 
transformed to equalise the variances before undertaking the unpaired student‟s t tests. 
For the comparisons of  control, E, F, E+F and also  control, T,F,T+F at times 0 and at 
240 mins, ANOVA on non-transformed data followed by the Bonferroni post-hoc test 
was performed. In this thesis, all the data are represented as bar graphs showing 
arithmetic means and SEM to show the comparisons between the control and treatment 
groups at time 0 and at 240 mins. 
The CT values obtained from QPCR of samples (COC) treated with forskolin or 
control (non forskolin treated), for each gene separately (i.e. Cx43 and Cx37) were 
calculated. The Cx43 mRNA results were corrected using the housekeeping RPL19 
gene values whereas the Cx37 gene results were not corrected by RPL19.The 
justification for this is referred to elsewhere (i.e. in the Discussion). The relative level 
of gene expression in individual COCs at 0 and 240 min of incubation for Cx37 and 
Cx43 were each averaged to calculate the means for the forskolin treated and control 
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groups. Thereafter, the unpaired student‟s t test was performed using SPSS 16.0 to 
compare gene expression in the control versus forskolin treatment group at 0 and 240 
mins and the data is represented as bar graphs.  
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RESULTS 
3.1 Quality of oocytes and cytoplasmic characteristics  
The impact of oocyte cytoplasm characteristics on fluorescence intensity is shown in 
Figure 3.1. The oocytes without any colour were first visualised under the inverted 
microscope prior to activation of the fluorescence system. The fluorescence intensity 
values were then assessed. Examples of these are shown in Fig 3.1 where the intensity 
values are highlighted in red for each respective oocyte. All denuded oocytes were 
from control group, without any treatments and fluorescence was measured at time 0. 
 
 
Figure 3.1:- Impact of oocyte cytoplasm characteristics on fluorescence intensity 
Normal cytoplasm   Granular cytoplasm  
232 
683 
167 
18 
46 
27 
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3.2 Effect of time on calcein dye transfer through gap junctions in rat COC 
The aim of this experiment with rat COC was to determine the effect of time of 
incubation on the rate of calcein dye transfer from the cumulus cells to the oocyte.   
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Figure 3.2:-Effect of incubation time on the relative fluorescence of calcein in 
denuded oocytes after exposing COC to a 10 min pulse of calcein-AM prior to 
incubation in calcein-free media. At each time point, the mean ± sem values were 
generated from 7 replicate experiments with 6-10 oocytes used in each replicate 
experiment. Means marked with asterisks are significantly different from 0 time 
period (*p<0.05; **p<0.01). 
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 The relative mean fluorescence values in denuded oocytes at 60, 120, 180, 240 
and 360 mins were significantly different from those at time 0 (p<0.01). The 
maximum dye transfer was observed at 180 to 240 mins. Thereafter, at 360 mins the 
relative level of fluorescence had declined by ~30% compared to that at 240 mins. For 
all subsequent experiments where the effects of steroids, IGF1, forskolin, dibutyryl 
cAMP and FSH were examined an incubation time of 240 mins for the COCs was 
selected.  
 
3.3 Effect of Steroids on gap junction activity 
 Steroids are present in high concentrations in follicular fluid and are also 
important secretory products of the follicle. Since COC are exposed to high steroid 
concentrations their effects on gap junction communication as assessed by calcein dye 
transfer was examined. The major steroids known to be present in follicular fluid are 
oestradiol, testosterone, androstendione and progesterone. The results of the effects of 
these steroids when added individually to COC are summarised in Figures 3.3(i), 
3.3(ii), 3.3(iii), 3.3(iv) respectively. The results show that the mean values after 
240min of incubation for both control and treatment groups were significantly higher 
than the corresponding values at time 0, and this effect was observed for all steroid 
treatments (p<0.05). No significant difference was observed for the mean 
fluorescence values between control and treatment groups at time 0 or after 240 min 
incubation, and this was observed for all steroid treatments (p>0.05). These results 
suggest that steroids do not affect gap junction activity in rat COCs.  
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Figure 3.3(i):- Effect of oestradiol and no treatment on fluorescent intensity of 
calcein in denuded oocytes at 0 and 240 min. For each treatment and time, the mean± 
sem values were generated from 6 replicate experiments with 6-10 oocytes in each 
replicate experiment. Means with different alphabetical superscripts are significantly 
different (p<0.05).  
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Figure 3.3(ii):- Effect of testosterone and no treatment on fluorescent intensity of 
calcein in denuded oocytes at 0 and 240 min. For each treatment and time, the mean± 
sem values were generated from 5 replicate experiments with 6-10 oocytes in each 
replicate experiment. Means with different alphabetical superscripts are significantly 
different (p<0.05).  
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Figure 3.3(iii):- Androstenedione does not affect calcein transfer from cumulus cells 
to the oocyte in vitro. For each treatment and time, the mean± sem values were 
generated from 5 replicate experiments with 6-10 oocytes in each replicate 
experiment. Means with different alphabetical superscripts are significantly different 
(p<0.05).  
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Figure 3.3(iv):- Progesterone does not affect calcein transfer from cumulus cells to 
the oocyte in vitro. For each treatment and time, the mean± sem values were 
generated from 5 replicate experiments with 6-10 oocytes in each replicate 
experiment. Means with different alphabetical superscripts are significantly different 
(p<0.05).  
 
3.4 Effect of IGF 1 on gap junction activity in rat COCs 
IGF1 plays an important role in follicular development by influencing the effects of 
FSH on granulosa cells in mammals. The effects of IGF1 on gap junction activity are 
not known and this was the basis for the present study. As shown in Figure 3.4, 
treatment of COCs with IGF1 alone had no effect on calcein transfer from cumulus 
cells to the oocyte as there was no significant difference in the mean fluorescence 
values after four hours of incubation between control and IGF1 treated COCs 
(p>0.05). 
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Figure 3.4:- IGF1 has no effect on calcein transfer from cumulus cells to the oocyte 
in vitro. For each treatment and time, the mean± sem values were generated from 5 
replicate experiments with 6-10 oocytes in each replicate experiment. Means with 
different alphabetical superscripts are significantly different (p<0.05). No difference 
in mean fluorescence intensity was observed between the IGF1 and control treatments 
at 0 or 240 min. 
 
3.5 Effect of Forskolin on gap junction activity in rat COCs 
 
High intracellular levels of cAMP in the oocyte are known to be important with 
respect to maintenance of meiotic arrest in vivo. In this and other experiments, the 
effect of stimulators of cAMP synthesis in COC was tested for their abilities to 
enhance calcein dye transfer from cumulus cells to the oocyte.  In this set of 
experiments the effect of forskolin on gap junction communication in vitro was 
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investigated. The results (Figure 3.5) indicate that treatment of COCs with forskolin 
increased gap junction activity since there was a significant difference in the mean 
fluorescence values after four hours of incubation between control and forskolin 
treated COCs (p<0.05). No significant difference was observed for the mean 
fluorescence values at time 0 between control and forskolin (p>0.05).  
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Figure 3.5:- Forskolin causes an increase in fluorescence intensity in denuded oocytes 
after 240 min incubation in vitro following a 10 min pulse of calcein followed by 
incubation of the COC in calcein free media for 0 and 240 min.  For each treatment 
and time, the mean± sem values were generated from 7 replicate experiments with 6-
10 oocytes in each replicate experiment. Means with different alphabetical 
superscripts are significantly different (p<0.05).  
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3.6 Effect of other cAMP stimulators 
In addition to forskolin, other factors likely to increase intracellular cAMP 
concentrations, such as dcAMP and FSH were tested for their abilities to enhance 
calcein dye transfer from cumulus cells to oocytes. The results from these 
experiments are summarised in Figures 3.6(i) and 3.6(ii).  
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Figure 3.6(i):-Dibutyryl cAMP causes an increase in calcein transfer from cumulus 
cells to the oocyte in vitro. For each treatment and time, the mean± sem values were 
generated from 5 replicate experiments with 6-10 oocytes in each replicate 
experiment. Means with different alphabetical superscripts are significantly different 
(p<0.05).  
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Figure 3.6(ii):- FSH causes an increase in calcein transfer from cumulus cells to the 
oocyte in vitro. For each treatment and time, the mean± sem values were generated 
from 5 replicate experiments with 6-10 oocytes in each replicate experiment. Means 
with different alphabetical superscripts are significantly different (p<0.05).  
 
 Thus as with forskolin, both dibuyryl cAMP and FSH treatments to COCs 
increased the level of fluorescent dye present in oocytes after 240 min in vitro.  
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3.7 Effects of various treatment combinations  
COCs within developing follicles are exposed to mixtures of steroid, IGF1 and cAMP 
stimulators. In the following experiments, rat COCs were treated with different 
combinations of steroids, IGF1 and forskolin to test their effects on gap junction 
activity. In all the following experiments i.e. testosterone + forskolin; testosterone + 
forskolin + IGF1; oestradiol + forskolin; oestradiol + forskolin+ IGF1, there were 
significant difference between control and treatments after 240 min (Figures 3.7 i-iv; 
all p<0.05) but no differences noted at time 0. The only exception to this was that no 
difference was observed for androstenedione + forskolin compared to the untreated 
controls after 240 min. 
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Figure 3.7(i):- Effect of testosterone + forskolin or no treatment on fluorescent 
intensity in denuded oocytes at 0 or 240 min. For each treatment and time, the mean± 
sem values were generated from 6 replicate experiments with 6-10 oocytes in each 
replicate experiment. Means with different alphabetical superscripts are significantly 
different (p<0.05).  
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Figure 3.7(ii):- Effect of testosterone + forskolin+ IGF1 on fluorescence intensity in 
denuded oocytes at 0 and 240 min. For each treatment and time, the mean± sem 
values were generated from 6 replicate experiments with 6-10 oocytes in each 
replicate experiment. Means with different alphabetical superscripts are significantly 
different (p<0.05).  
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Figure 3.7(iii):-Effect of oestradiol + forskolin or no treatment on fluorescence 
intensity in denuded oocytes at 0 or 240 min. For each treatment and time, the mean± 
sem values were generated from 6 replicate experiments with 6-10 oocytes in each 
replicate experiment. Means with different alphabetical superscripts are significantly 
different (p<0.05).  
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Figure 3.7(iv):- Effect of oestradiol + Forskolin + IGF1 and no treatment on the 
fluorescent intensity in denuded oocytes at 0 and 240 min. For each treatment and 
time, the mean± sem values were generated from 5 replicate experiments with 6-10 
oocytes in each replicate experiment. Means with different alphabetical superscripts 
are significantly different (p<0.05).  
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Figure 3.7(v):- Effect of androstenedione + forskolin and no treatment on the 
fluorescent intensity in denuded oocytes at 0 and 240 min. For each treatment and 
time, the mean± sem values were generated from 5 replicate experiments with 6-10 
oocytes in each replicate experiment. Means with different alphabetical superscripts 
are significantly different (p<0.05).  
 
3.8 Effect of various combination of treatments on COCs in the same 
experiments 
In these set of experiments, the effect of treatments on gap junction activity of COCs 
was compared by treating the COCs from the same rat with different combinations of 
treatments earlier used. The aims were to test whether any of the combinations added 
to or negated any of the effects observed with forskolin alone. The combinations 
tested in the same experiments were: no treatment, testosterone, forskolin and, 
testosterone + forskolin and; no treatment, oestradiol, forskolin and, oestradiol + 
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forskolin. These results are summarised in Figures 3.8(i) and (ii). The results from the 
testosterone and forskolin combinations show that the forskolin treatments enhanced 
dye transfer relative to the controls and that testosterone did not enhance the effects of 
forskolin when both were added to the incubation media. Testosterone alone did not 
enhance fluorescence transfer relative to the untreated control (see Figure 3.7(i)). 
Likewise, the results from the Oestradiol and forskolin combinations show that the 
forskolin treatments enhanced dye transfer relative to the controls and that oestradiol 
did not enhance significantly the effects of forskolin. 
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Figure 3.8(i):- Effects of no treatment, testosterone, forskolin and testosterone + 
forskolin (T + F) on the fluorescence intensities in denuded oocytes at 0 and 240 min. 
Bars represent mean+sem fluorescence values for control and treated COCs at 0 time 
period and after four hours of incubation. For each treatment and time, the mean± sem 
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values were generated from 5 replicate experiments with 6-10 oocytes in each 
replicate experiment. Means with different alphabetical superscripts are significantly 
different (p<0.05).  
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Figure 3.8(ii):- Effects of no treatment, oestradiol, forskolin and oestradiol + 
forskolin (Oestradiol + F) on the fluorescence intensities in denuded oocytes at 0 and 
240 min. Bars represent mean+sem fluorescence values for control and treated COCs 
at 0 time period and after four hours of incubation. For each treatment and time, the 
mean± sem values were generated from 5 replicate experiments with 6-10 oocytes in 
each replicate experiment. Means with different alphabetical superscripts are 
significantly different (p<0.05).  
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3.9 QPCR results 
The effects of forskolin on Cx37 and Cx42 gene expression levels in rat COC were 
examined. For both Cx 37 and Cx43, no differences in relative levels of gene 
expression were noted at time 0 between forskolin treated and control groups. As 
shown in Figure 3.9(i), there was a significant difference in the relative gene 
expression levels of Cx37 between control and forskolin treated groups after 240mins 
(p<0.05). However, no significant differences were observed in the relative gene 
expression levels of Cx43 between control and forskolin treated groups after 240mins 
(Figure 3.9(ii); p>0.05).  
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Figure 3.9(i):- Effect of no treatment and forskolin on the relative Cx37 gene 
expression in COC at 0 and 240mins. The bar graphs represent the mean± sem values 
for each treatment and means with different alphabetical superscripts are significantly 
different (p<0.05).  
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Figure 3.9(ii):- Effect of no treatment and forskolin on the relative Cx43 gene 
expression in COC at 0 and 240mins. Values are corrected against RPL19.The bar 
graphs represent the mean± sem values for each treatment and means with different 
alphabetical superscripts are significantly different (p<0.05).  
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DISCUSSION 
 
The major aims in this thesis, investigating COCs recovered from antral 
follicles, were: to 1) establish an optimal time in vitro for maximising the transfer of 
calcein dye from the cumulus cells to the oocyte while maintaining the oocyte in 
meiotic arrest and; 2) determine the effects of steroids, growth factors and cAMP 
stimulators on the level of fluorescent dye in the oocyte as a measure of gap junction 
activity in rat COC. 
The application of the Calcein fluorescent dye transfer technique to measure 
gap junction activity was first reported by Thomas et al, in bovine COC (6). This 
report validated the finding that the water-soluble and cleaved form of Calcein was 
unable to exit cells across the cell wall but could only move from one cell to another 
via gap-junction. This technique has recently been validated for application in porcine 
COC (100) but has not to our knowledge been investigated in other species.  
To carry out the assay, only oocytes with at least two layers of intact cumulus 
cells around the oocyte were selected. During this study it was noted that the visible 
characteristics of the oocyte cytoplasm influences the level of fluorescence intensity 
measured Fig 3.1. Some oocytes had comparatively lower fluorescence intensities 
than oocytes with visibly normal cytoplasm. These oocytes with low fluorescence 
readings had a characteristic “granular” cytoplasm. This trend was observed in all 
oocytes characterised as granular, regardless of what treatment were they subjected to 
and the time after which they were examined. The granular and normal (agranular) 
cytoplasm‟s were variable over all the experiments. Despite differences in 
fluorescence being noted based on granulosa characteristics, the fluorescence readings 
of such oocytes were included in all further analyses. Furthermore, no significant 
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difference between rats in COC readings was observed therefore the results were 
pooled across the experiments.  
Following the exposure of COC to a 10 min exposure of Calcein, followed by 
incubation of the COC in Calcein-free media, it was evident that dye transfer from 
cumulus cells to the oocyte increased over a 180-240 min interval (see Figure 3.2) in 
the absence of any hormones or growth factors. This suggested that the initial 
isolation of COC from its follicular environment caused a disruption of gap junction 
activity. This may have been due to the stress imposed on the oocyte as a result of 
removing the COC from its gap junction network with the mural granulosa cells. If 
this notion is correct, then the evidence from this study showed that the COC gap 
junction activity can recover over time in vitro. After 240 min, a decrease in the gap 
junction activity was observed despite the presence of the PDE inhibitor milrinone. 
Thus, even though the COC were placed into a nutrient rich culture media, this alone 
was not sufficient to sustain the COC gap junction communication. An alternative 
explanation might be that the optimal time for maintenance of Calcein dye at 
maximum intensity in the oocyte is influenced by the exposure time and/or 
concentration of Calcein. These parameters were not tested in the present study.  
 In antral fluid, follicular-derived steroids are present at variable but relatively 
high concentrations during folliculogenesis. There is evidence that steroids influence 
follicular growth including granulosa cell proliferation and differentiation (101, 102). 
The hormonal microenvironment in vivo is often used as an indicator of the 
maturation potential of an individual follicle to develop to ovulation (103). Within 
this follicular microenvironment, COCs are exposed to relatively high concentrations 
of androgens i.e. testosterone and androstenedione. These androgens are also the 
major substrates for oestradiol synthesis by the granulosa cells. Our study suggests 
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that steroids alone do not have any effect on COC gap junction activity in vitro. None 
of the steroids tested i.e. oestradiol, testosterone, androstenedione and progesterone 
(See Fig 3.3 i-iv) caused any change in gap junction activity of rat COCs. In previous 
studies, it has been shown that the treatment of sexually immature rats with oestrogen 
implants leads to an increase in Cx43 protein expression (104). Burghardt et al 1982 
demonstrated that exogenous oestradiol promotes gap junction growth indirectly in rat 
granulosa cells. They showed that the development of gap junctions occur at a basal 
rate in the absence of steroids, however exogenous oestradiol prevented atresia and 
promoted follicular growth during which an increase in gap junctions was observed. 
Therefore, it seems that oestradiol didn‟t directly cause an increase in gap junction 
activity in granulosa cells but as follicular growth was sustained the basal rate of gap 
junction activity continued over a more extended period (105). The findings from that 
study are not inconsistent with our results since we didn‟t observe any direct effect of 
oestradiol on gap junction activity in rat COC under in vitro conditions. Moreover, 
any indirect measures of the effects of steroids on sustaining follicular growth were 
beyond the scope of the present study. Nevertheless, it is acknowledged that steroids 
are indicative of the functional status of a follicle at any moment in time.  
It is well known that the concentrations of pituitary and steroid hormones 
change throughout the menstrual or ovarian cycle and that they change in a specific 
sequence within the developing follicular environment which influences growth and 
secretory activity of granulosa cells (101). In the present study we tested the effects of 
steroids at a single concentration of 1 µg/ml. It has been found that the dominant 
oestrogen-secreting follicle contains 1µg of oestradiol per millilitre of antral fluid in 
many species and that the concentrations of androstenedione, testosterone and 
progesterone can, at times approach these levels (102). However, steroids do vary 
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significantly in their concentrations in follicular fluid. It is therefore possible that 
steroidal effects might be observed at lower concentrations but this was not 
investigated. Oestrogen is thought to be a key steroid and essential for cytoplasmic 
maturation and in the absence of oestrogen, granulosa cells fail to proliferate (102; 
106). However, our study suggests that these processes are unlikely to be influenced 
directly by the effects of oestradiol on gap junction activity. 
 The present results demonstrate that IGF1 alone at a concentration of 10ng/ml 
was unable to show any effect on gap junction activity in rat COC. Previous studies 
have reported that more gap junctions both among granulosa cells or theca cells and 
between granulosa cells and the oocyte were observed in follicles cultured in the 
presence of IGF-I (98). In comparison to our findings, Zhao et al analysed the effect 
of IGF1 on preantral follicles however their measures of gap junction formation were 
qualitative rather than quantitative.  
 The role of forskolin, a cAMP stimulator, was examined in this study and an 
increase in gap junction activity was observed when compared to COCs without 
treatment (See Fig 3.5). In contrast with our results, studies with bovine COC showed 
that treatment of COCs with forskolin prolonged the maintenance of gap junction 
communication by preventing the loss of gap junctions (6). This study also 
demonstrated that the effect of forskolin in delaying the loss of gap junctions was 
enhanced by the presence of milrinone, a PDE3 inhibitor. While milrinone was also 
present in all our studies, we did not test the effects of time on maintaining gap 
junction activity nor was the effect of excluding milrinone tested. Previous studies 
have shown that forskolin inhibits the spontaneous maturation of rat and bovine 
oocytes in vitro and maintained them in meiotic arrest (6, 92). Moreover, the arresting 
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action of forskolin was dependent upon the presence of surrounding cumulus cells, as 
cumulus free oocytes underwent GVBD.  
 In the present study, although steroids or IGF1 alone didn‟t show any effect on 
gap junction activity, the combined effect of various steroids or IGF1 and forskolin 
(See Fig 3.7 i-v) caused an increase in dye transfer via gap junctions from cumulus 
cells to the oocyte. The only exception to this was the results of the study with 
androstenedione+ forskolin. In this study, the androstenedione+ forskolin values were 
1.3 fold higher than the control but this did not reach statistical significance. 
Nevertheless, from these results it was of interest to know if whether the increases in 
gap junction activity were solely due to forskolin since it was the only factor that 
earlier demonstrated an ability to increase dye transfer or whether due to the 
cumulative effects of steroids or IGF1 and forskolin. The results from our studies 
summarised in Fig 3.8 (i), (ii) suggests that the addition of steroids did not enhance 
the effects of forskolin when both were added to the incubation media indicating that 
forskolin alone was responsible for the increase in gap junction activity. While the 
effects of forskolin+IGF1 were not compared to those of forskolin alone, it seems 
likely that the significant effects of the former were due to forskolin alone.  
 Other cAMP stimulators or analogues such as FSH and dcAMP also caused 
significant increases in the amount of dye transfer (See Fig 3.6(i); 3.6(ii)). It has been 
well established that FSH drives antral follicle growth in vivo and that the presence of 
this hormone is essential to obtain developmentally competent oocytes in vitro (93). 
Previously, Burghardt et al 1982 reported that FSH causes gap junction amplification 
directly in rat granulosa cells. FSH amplified both the number of junctions and the 
amount of junctional membranes at all follicle sizes that were examined (105). In 
contrast, studies on porcine COC using the Calcein dye technique published by Bagg 
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et al 2009 were unable to demonstrate that exposure of COC to cAMP from either 
small or medium to large follicles increased gap junction in vitro over the first 6 h 
period. Significantly, at that time no significant difference was noted in the intra-
oocyte cAMP concentrations between the cAMP and non-cAMP treated groups (110). 
In that study there was no evidence that a PDE inhibitor was used. Perhaps the lack of 
effect on gap junction activity was the result of insufficient elevation of intra-COC 
concentrations of cAMP.  
Our results with FSH or dbcAMP are consistent with those of forskolin and 
suggest that any agents that elevate cAMP intraoocyte levels are likely to cause an 
increase in dye or reagent transfer from cumulus cells to the oocyte by increasing gap 
junction activity (105, 107). Importantly, we only tested gap junction communication 
in COCs after four hours of incubation and did not investigate any other effects of 
cAMP modulating agents after this time period. With respect to exploring the 
improved efficacies for IVM, it will be important to investigate the effects of longer 
term exposure of COC to cAMP stimulators.  
FSH stimulates cAMP by first binding to membrane receptors and activating 
G proteins in cumulus cells, which in turn activates adenylate cyclase activity leading 
to an increased synthesis of cAMP (108). Forskolin has also demonstrated its ability 
to increase intraoocyte cAMP levels, since it very rapidly activates the catalytic 
subunit of adenylate cyclase (91). It has been reported that an increase in intraoocyte 
cAMP levels causes increased intercellular gap junction communication most likely 
as a result of increased connexin RNA or protein levels (109). A previous study has 
demonstrated that cAMP can also increase gap junctional permeability by increasing 
assembly of Cx43 to plasma membrane gap junctional plaques (110).  
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It is well known that cAMP plays a crucial role in mammalian oocyte 
maturation. High levels of cAMP within the oocyte maintain oocyte meiotic arrest, 
whereas a fall in cAMP enables resumption of meiosis. Both forskolin and dcAMP 
display an inhibitory effect on oocyte maturation and this inhibitory effect is cAMP 
mediated (92, 111). In our study, it is suggested that forskolin, FSH and dcAMP 
stimulated cAMP production in the cumulus cells which is then transferred to the 
oocyte. This is consistent with previous results showing that higher levels of cAMP 
are present in oocytes derived from forskolin-stimulated COCs compared to similarly 
stimulated cumulus-free oocytes (112). It has been suggested that in vivo GVBD 
caused after the LH surge is cAMP mediated i.e. LH causes a rise in follicular cAMP 
in mural granulosa cells that luteinise leading to a progressive breakdown of gap 
junction communication across the ganulosa cell-cumulus cell syncytium (60). In the 
present in vitro studies the intra-oocyte cAMP levels that were generated as a result of 
forskolin, FSH and dcAMP treatments were unlikely during a 4 hour interval to have 
been high enough to interfere with intercellular communication as compared with the 
entire follicle in vivo where the cAMP produced by the whole follicle over a longer 
time interval is much greater.  
In order to explain how cAMP modulating agents lead to an increase in gap 
junction activity, one possibility is that elevated cAMP levels restores or maintains 
pre-existing gap junction connections in vitro. Another possibility could be that 
elevated cAMP levels induce connexin gene expression and in turn this then leads to 
an increase in gap junction protein.  
In the present study, the relative mRNA levels of Cx37 and Cx43 in COC after 
0 and 240 min of incubation were examined. From our QPCR results (refer to Fig 
3.9(i); (ii)) it can be observed that in both control and treatment groups, the relative 
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levels of Cx37 mRNA increased over 240min of incubation. Moreover, treatment of 
COCs with forskolin caused a significant increase in Cx37 gene expression when 
compared with COCs without any treatment (control) at 240 min. In contrast, the 
relative Cx43 mRNA levels decreased after 240 min incubation and no difference was 
observed in gene expression levels of Cx43 when compared with the control group. 
Since Cx43 is present in cumulus cells and in order to prevent any variation caused by 
the number of cumulus cells attached to each oocyte examined, the data for Cx43 was 
corrected against the relative expression levels of the housekeeping gene (RPL19). 
Furthermore, since Cx37 levels were analysed in one individual oocyte per 
experiment, it isn‟t likely to have caused variation and in turn we didn't correct our 
Cx37 results with RPL19.   A key issue to address here is the possibility that there 
may be some variation introduced by the housekeeping gene itself since it is present 
in both cumulus cells and the oocyte. However we selected for similar sized COCs 
and treated them with the same treatment i.e. forskolin, thereby it is unlikely to 
influence the results observed with Cx43.        
 It seems clear from these results that the elevated cAMP levels caused by 
forskolin increase the levels of Cx37 gene expression. However, further studies with 
respect to measures of Cx43 are required in order to examine changes when corrected 
with more localised housekeeping genes i.e. genes only present in cumulus cells and 
not within the oocyte.  
Gap junction communication involves a sequence of events including 
connexin synthesis (transcription and translation), trafficking to plasma membrane 
and connexon assembly. It is likely that each event in this sequence is regulated by 
phosphorylation steps involving the cAMP mediated cascades. Therefore we propose 
that cAMP may lead to elevated or maintained connexin mRNA levels to thereby 
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promote gap junctional permeability. It has previously been reported that the 
upregulation of junctional communication can be induced by cAMP which facilitated 
an increase in gap junctional plaques recognized by freeze fracture analysis (113). 
With respect to IVM, the inclusion of a specific PDE3 inhibitor such as 
milrinone and cAMP modulating agents in media are both likely to be important for 
enhancing the developmental potential of oocytes collected as COC from antral 
follicles not considered to have reached the preovulatory stage of maturation. We 
propose that the use of milrinone with forskolin or FSH or dcAMP will elevate intra-
oocyte cAMP, inhibit the resumption of meiosis and importantly promote gap 
junction communication thereby prolonging the opportunity for exchange of essential 
metabolites from the cumulus cells to the oocyte to advance cytoplasmic maturation 
in oocytes.  
Important future directions include examining the effects of the oocyte-
secreted factors such as GDF9 and BMP15. As outlined earlier, both GDF9 and 
BMP15 have essential regulatory roles in ovarian follicular development (78). Studies 
have shown that when COCs are treated with exogenous GDF9 and BMP15, an 
improved oocyte developmental potential is observed (114). Such treatments were 
shown to cause a 50% increase in developmental competence as well as improved 
embryo quality. It has also been demonstrated that the addition of GDF9 in IVM 
media increases the embryo production efficiency in mice (114). Furthermore, 
analysing the effects of cAMP stimulators at various concentrations for longer time 
intervals together with further information on connexin 37 and 43 mRNA and protein 
synthesis as well as other culture/incubation media supplements would provide new 
insights into improving the applications of IVM in artificial reproductive 
technologies.  
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CONCLUSION 
 
 
In this study, we determined the effects of various factors on the gap junction activity 
in rat COCs. Isolation of rat COC from their follicular microenvironment appears to 
impair gap junction activity within COCs as assessed by the measurement of dye 
transfer however this activity was recovered over time in vitro. Under in vitro 
conditions all cAMP stimulators i.e. forskolin, FSH, dcAMP together with milrinone 
caused an increase in gap junction activity between cumulus cells and the oocyte. 
Steroids and IGF1 alone didn‟t show any effect on gap junction activity. Furthermore, 
forskolin caused an increase in the relative Cx37 gene expression levels after a four 
hour incubation period.  
Together the findings from this study suggest that cAMP stimulators are important in 
terms of maintenance of gap junction permeability between cumulus cells and the 
oocyte in rats and in order to develop an in vitro maturation culture medium, it is vital 
to incorporate agents that elevate intraoocyte cAMP levels.  
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Appendix1:- Company addresses 
Company  Address 
Invitrogen  Penrose Auckland 1006, New Zealand 
Sigma-Aldrich Auckland 1030, New Zealand 
Novozymes  Bagsvaerd 2880, Denmark 
Prospec  Rehovot 76103, Israel 
Epicentre  Madison, WI153713, USA 
Corbett Research Mortlake NSW 2137, Australia 
Stratagene  La Jolla 92037, CA 
 
 
 
